ABT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ABT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-10-31), the Forward Annual Dividend Yield of Abbott Laboratories is 1.92%.
As of today (2024-10-31), the Trailing Annual Dividend Yield of Abbott Laboratories is 1.92%.
Abbott Laboratories's Dividends per Share for the three months ended in Jun. 2024 was $0.55.
During the past 12 months, Abbott Laboratories's average Dividends Per Share Growth Rate was 8.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 12.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 13.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 11.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Abbott Laboratories was 22.90% per year. The lowest was -31.20% per year. And the median was 11.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
For the Medical Devices subindustry, Abbott Laboratories's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Abbott Laboratories Recent Full-Year* Dividend History
Amount | Ex-date | Record Date | Pay Date | Type | Frequency | Forex Rate |
---|---|---|---|---|---|---|
USD 0.550000 | 2024-10-15 | 2024-10-15 | 2024-11-15 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.550000 | 2024-07-15 | 2024-07-15 | 2024-08-15 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.550000 | 2024-04-12 | 2024-04-15 | 2024-05-15 | Cash Dividend | quarterly | USD:USD 1.000000 |
USD 0.550000 | 2024-01-11 | 2024-01-12 | 2024-02-15 | Cash Dividend | quarterly | USD:USD 1.000000 |
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Abbott Laboratories's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield | = | Forward Full Year Dividend | / | Current Share Price |
= | 2.2 | / | 113.37 | |
= | 1.94 % |
Current Share Price is $113.37.
Abbott Laboratories's Dividends per Share for the forward twelve months is calculated as $0.55 * 4 = $2.2.
Abbott Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield | = | Most Recent Full Year Dividend | / | Current Share Price |
= | 2.2 | / | 113.37 | |
= | 1.94 % |
Current Share Price is $113.37.
Abbott Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.2.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (NYSE:ABT) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.
Thank you for viewing the detailed overview of Abbott Laboratories's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert B Ford | officer: Senior Vice President | 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092 |
Mccoy John A. Jr. | officer: VICE PRESIDENT | C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Robert E Funck | officer: Vice President, Controller | 100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092 |
Lisa D Earnhardt | officer: Executive Vice President | 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025 |
Salvadori Daniel Gesua Sive | officer: Senior Vice President | 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092 |
Mary K Moreland | officer: Executive Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Hubert L Allen | officer: Executive Vice President | 100 ABBOTT PARK ROAD, AP6C-1N, ABBOTT PARK IL 60064-6092 |
Louis H. Morrone | officer: EXECUTIVE VICE PRESIDENT | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Andrea F Wainer | officer: Executive Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Daniel J Starks | director | ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117 |
Michael F Roman | director | 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000 |
Patricia Paola Gonzalez | director | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Philip P Boudreau | officer: Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Michael O'grady | director | 50 S LASALLE STREET, CHICAGO IL 60603 |
Gregory A Ahlberg | officer: Senior Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
From GuruFocus
By PRNewswire • 06-27-2024
By ACCESSWIRE • 08-07-2024
By PRNewswire • 07-18-2024
By ACCESSWIRE • 07-24-2024
By GuruFocus Research • 08-02-2024
By PRNewswire • 09-19-2024
By GuruFocus Research • 09-18-2024
By GuruFocus Research • 07-19-2024
By GuruFocus Research • 09-04-2024
By PRNewswire • 09-25-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.